DMF ‘reduces disease activity long-term in MS’
DMF ‘reduces disease activity long-term in MS’
Delayed-release dimethyl fumarate (DMF, also known as gastro-resistant DMF) is effective at lowering disease activity long-term in patients with relapsing-remitting multiple sclerosis (RRMS), according to Eva Havrdova, MD, of Charles University of Prague... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/